{"disease":{"id":"pregnancy-ovarian","name":"pregnancy ovarian"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03463278","title":"The Number of Blastocysts Formed in the Outcome of Freeze All Strategy: COMFFETI Trial, Cumulative Delivery Rate","phase":"","overall_status":"UNKNOWN","enrollment_count":160,"lead_sponsor_name":"Assisting Nature","has_results":false},{"nct_id":"NCT04175990","title":"IVF Outcome Following Progestogen Ovarian Stimulation","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":155,"lead_sponsor_name":"National University of Malaysia","has_results":false},{"nct_id":"NCT03240159","title":"Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Assisting Nature","has_results":false},{"nct_id":"NCT03684421","title":"Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Classical Antagonist Protocol","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Assisting Nature","has_results":false},{"nct_id":"NCT03693534","title":"Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Long Agonist Protocol","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Assisting Nature","has_results":false},{"nct_id":"NCT04797338","title":"Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Assaf-Harofeh Medical Center","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}